Proscillaridin is a cardiac glycoside that is derived from plants of the genus Scilla and in Drimia maritima (Scilla maritima). Studies suggest the potential cytotoxic and anticancer property of proscillaridin, based on evidence of the drug potently disrupting topoisomerase I and II activity at nanomolar drug concentrations and triggering cell death and blocking cell proliferation of glioblastoma cell lines. It is grouped under the following drug class(es): Glycosides. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Proscillaridin A and Talusin. Its PubChem CID is 5284613.
Proscillaridin
| CAS No | 466-06-8 |
|---|---|
| Molecular Formula | C30H42O8 |
| Molecular Weight | 530.6 g/mol |
| Synonyms | 5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Proscillaridin is a cardiac glycoside that is derived from plants of the genus Scilla and in Drimia maritima (Scilla maritima).
The listed CAS number is 466-06-8.
The listed molecular formula is C30H42O8.
The listed molecular weight is 530.6 g/mol.
5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one.
The source lists Proscillaridin A and Talusin.